84 related articles for article (PubMed ID: 28735774)
1. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.
Hobday S; Valerio H; Combo T; Monaghan R; Scott C; Silk D; Murray C; Read P; Henderson C; Degenhardt L; Treloar C; Dore GJ; Grebely J; Martinello M;
Drug Alcohol Rev; 2023 Nov; 42(7):1617-1632. PubMed ID: 37556376
[TBL] [Abstract][Full Text] [Related]
3. Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.
Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB;
Drug Alcohol Rev; 2024 May; 43(4):1019-1028. PubMed ID: 38630939
[TBL] [Abstract][Full Text] [Related]
4. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH
J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia.
Read P; Tang BZH; Silins E; Doab A; Cornelisse VJ; Gilliver R
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932249
[TBL] [Abstract][Full Text] [Related]
6. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
7. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico.
Aponte-Meléndez Y; Eckhardt B; Fong C; Padilla A; Trinidad-Martínez W; Maldonado-Rodríguez E; Agront N; Mateu-Gelabert P
J Subst Use Addict Treat; 2024 May; 160():209308. PubMed ID: 38301921
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.
Nassau T; Al-Tayyib A; Robinson WT; Shinefeld J; Brady KA
Public Health Rep; 2020; 135(1_suppl):138S-148S. PubMed ID: 32735193
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine.
Iakunchykova O; Meteliuk A; Zelenev A; Mazhnaya A; Tracy M; Altice FL
Int J Drug Policy; 2018 Jul; 57():11-17. PubMed ID: 29655101
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review.
Abdul-Quader AS; Feelemyer J; Modi S; Stein ES; Briceno A; Semaan S; Horvath T; Kennedy GE; Des Jarlais DC
AIDS Behav; 2013 Nov; 17(9):2878-92. PubMed ID: 23975473
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J;
Int J Drug Policy; 2024 May; 127():104394. PubMed ID: 38608357
[TBL] [Abstract][Full Text] [Related]
14. Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
Echevarria D; Gutfraind A; Boodram B; Major M; Del Valle S; Cotler SJ; Dahari H
PLoS One; 2015; 10(8):e0135901. PubMed ID: 26295805
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q; Valerio H; Cunningham EB; Shih STF; Silk D; Conway A; Treloar C; Murray C; Henderson C; Amin J; Read P; Dore GJ; Grebely J;
Value Health; 2024 Feb; 27(2):216-225. PubMed ID: 37951538
[TBL] [Abstract][Full Text] [Related]
16. Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.
Paquette CE; Pollini RA
Drug Alcohol Depend; 2018 Jul; 188():239-250. PubMed ID: 29787966
[TBL] [Abstract][Full Text] [Related]
17. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
18. The role of social networks and geography on risky injection behaviors of young persons who inject drugs.
Boodram B; Mackesy-Amiti ME; Latkin C
Drug Alcohol Depend; 2015 Sep; 154():229-35. PubMed ID: 26169447
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Correlates of Injecting with Visitors from the United States Among People Who Inject Drugs in Tijuana, Mexico.
Bórquez A; Garfein RS; Abramovitz D; Liu L; Beletsky L; Werb D; Mehta SR; Rangel G; Magis-Rodríguez C; González-Zúñiga P; Strathdee SA
J Immigr Minor Health; 2019 Dec; 21(6):1200-1207. PubMed ID: 30771144
[TBL] [Abstract][Full Text] [Related]
20. Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.
Prevost TC; Presanis AM; Taylor A; Goldberg DJ; Hutchinson SJ; De Angelis D
Addiction; 2015 Aug; 110(8):1287-300. PubMed ID: 25876667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
